Alterity Therapeutics Limited
PRNAF
$0.01
$0.00-44.55%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,068.94% | 934.60% | 216.11% | 207.67% | -66.57% |
| Total Receivables | 29.75% | 14.84% | -4.27% | -6.82% | -13.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -47.68% | -49.07% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 299.31% | 253.36% | 1.11% | -1.51% | -94.82% |
| Total Current Assets | 487.15% | 419.67% | 136.77% | 130.46% | -56.94% |
|
|
|||||
| Total Current Assets | 487.15% | 419.67% | 136.77% | 130.46% | -56.94% |
| Net Property, Plant & Equipment | -10.61% | -21.05% | -18.44% | -20.59% | -47.35% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 481.68% | 414.83% | 135.26% | 128.99% | -56.85% |
|
|
|||||
| Total Accounts Payable | -16.10% | -25.74% | -8.98% | -11.42% | -48.73% |
| Total Accrued Expenses | 72.63% | 52.75% | -37.58% | -39.24% | -18.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -43.30% | -49.89% | -38.60% | -40.34% | -68.22% |
| Total Finance Division Other Current Liabilities | 0.00% | -11.67% | -73.10% | -73.91% | -42.16% |
| Total Other Current Liabilities | 0.00% | -11.67% | -73.10% | -73.91% | -42.16% |
| Total Current Liabilities | 2.54% | -9.25% | -35.37% | -37.09% | -45.08% |
|
|
|||||
| Total Current Liabilities | 2.54% | -9.25% | -35.37% | -37.09% | -45.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 63.67% | 44.82% | 67.92% | 62.83% | -48.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.49% | -8.41% | -34.38% | -36.13% | -45.15% |
|
|
|||||
| Common Stock & APIC | 36.23% | 20.57% | 15.79% | 12.70% | -5.61% |
| Retained Earnings | -14.31% | -1.17% | -3.64% | -0.88% | 0.49% |
| Treasury Stock & Other | 25.36% | 10.95% | 9.22% | 6.31% | 11.94% |
| Total Common Equity | 651.25% | 564.91% | 201.97% | 193.91% | -59.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 651.25% | 564.91% | 201.97% | 193.91% | -59.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 651.25% | 564.91% | 201.97% | 193.91% | -59.89% |
|
|
|||||